AR and COVID-19: Using a retrospective cohort design with patients in the Department of Veterans Affairs healthcare system, we use doubly robust regression and matching to estimate the association between baseline use of α<sub>1</sub>-AR antagonists and likelihood of death due to COVID-19 during hospitalization.